Growth Metrics

Mannkind (MNKD) Total Non-Current Liabilities (2012 - 2026)

Mannkind (MNKD) reported Total Non-Current Liabilities of $798.5 million for Q1 2026, down 4.73% on a QoQ basis from $838.1 million in Q4 2025.

Mannkind (MNKD) has 15 years of Total Non-Current Liabilities data on file, last reported at $798.5 million in Q1 2026.

  • Quarterly Total Non-Current Liabilities changed N/A year-over-year to $798.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $798.5 million (changed N/A YoY) and the FY2025 annual result came in at $838.1 million, changed N/A from the prior year.
  • Total Non-Current Liabilities retreated to $798.5 million in Q1 2026 per MNKD's latest filing, from $838.1 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $838.1 million in Q4 2025 and bottomed at -$55000.0 in Q4 2022.
  • The 5-year median for Total Non-Current Liabilities is $553.5 million (2023), against an average of $526.4 million.
  • The widest annual swing landed in 2022, when Total Non-Current Liabilities plunged 100.01%; it then surged 265107.27% in 2023.
  • Tracing MNKD's Total Non-Current Liabilities over 5 years: stood at -$55000.0 in 2022, then surged by 265107.27% to $145.8 million in 2023, then jumped by 387.67% to $710.8 million in 2024, then climbed by 17.91% to $838.1 million in 2025, then dropped by 4.73% to $798.5 million in 2026.
  • Per Business Quant, the three latest MNKD Total Non-Current Liabilities figures stand at $798.5 million (Q1 2026), $838.1 million (Q4 2025), and $710.8 million (Q1 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 11.03 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 42,980.09
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 95.20 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 110.28 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 5.87 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 7.32 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 4.05 Bn
10 Mannkind 1.09 Bn 956.66 Mn 82.66 Mn 798.45 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 798.45 Mn
Dec 31, 2025 838.09 Mn
Mar 31, 2024 710.79 Mn
Dec 31, 2023 145.75 Mn
Sep 30, 2023 572.05 Mn
Jun 30, 2023 573.85 Mn
Mar 31, 2023 553.48 Mn
Dec 31, 2022 -55,000.00
Sep 30, 2022 531.46 Mn
Jun 30, 2022 532.77 Mn
Mar 31, 2022 533.33 Mn
Dec 31, 2021 525.56 Mn
Sep 30, 2021 422.61 Mn
Jun 30, 2021 436.17 Mn
Mar 31, 2021 488.25 Mn
Dec 31, 2020 284.88 Mn
Sep 30, 2020 276.25 Mn
Jun 30, 2020 277.95 Mn
Mar 31, 2020 275.00 Mn
Dec 31, 2019 282.25 Mn
Jun 30, 2019 268.66 Mn
Mar 31, 2019 281.00 Mn
Dec 31, 2018 275.95 Mn
Sep 30, 2018 245.11 Mn
Jun 30, 2018 264.21 Mn
Mar 31, 2018 281.62 Mn
Dec 31, 2017 296.96 Mn
Sep 30, 2017 306.33 Mn
Jun 30, 2017 300.01 Mn
Mar 31, 2017 273.92 Mn
Dec 31, 2016 283.28 Mn
Sep 30, 2016 317.42 Mn
Jun 30, 2016 489.34 Mn
Mar 31, 2016 450.79 Mn
Dec 31, 2015 470.36 Mn
Sep 30, 2015 388.09 Mn
Jun 30, 2015 455.90 Mn
Mar 31, 2015 430.27 Mn
Dec 31, 2014 455.91 Mn
Sep 30, 2014 415.92 Mn
Jun 30, 2014 267.64 Mn
Mar 31, 2014 192.70 Mn
Dec 31, 2013 275.75 Mn
Sep 30, 2013 435.02 Mn
Jun 30, 2012 479.85 Mn